Education
About Us
Working with TipRanks
Follow Us
Progyny, Inc. (PGNY)
:PGNY
PGNY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$13.39 - $30.42
Previous CloseN/A
Volume466.97K
Average Volume (3M)1.07M
Market Cap
$1.99B
Enterprise Value$2.76B
Total Cash (Recent Filing)$256.12M
Total Debt (Recent Filing)$26.00M
Price to Earnings (P/E)41.0
Beta0.76
Next Earnings
Aug 07, 2025EPS Estimate
0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.17
Shares Outstanding85,718,025
10 Day Avg. Volume1,151,878
30 Day Avg. Volume1,071,752
Financial Highlights & Ratios
PEG Ratio-1.71
Price to Book (P/B)7.62
Price to Sales (P/S)0.00
P/FCF Ratio37.22
Enterprise Value/Market Cap1.39
Enterprise Value/Revenue0.59
Enterprise Value/Gross Profit10.34
Enterprise Value/Ebitda9.65
Forecast
1Y Price Target
$27.25Price Target Upside17.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Progyny News
PremiumCompany Announcements
Progyny Secures $200M Credit Facility with JPMorganBulls Say, Bears Say
Bulls Say
Analyst UpgradeAnalyst recommends upgrading Progyny from Market Perform to Outperform with a maintained price target, indicating increased confidence in the stock.
Financial PerformancePGNY provided some early 2Q color, noting it expects revenue, adjusted net income, and adjusted EBITDA to be above the ranges provided earlier.
Membership ActivityProgyny's second positive preannouncement in six months is yet another signal that membership activity has rebounded from last year's lows.
Bears Say
Client MetricsThe average number of lives at prospective clients is lower compared to last year.
Service Continuation UncertaintyContinuation services for Amazon customers are expected to contribute more revenue, creating noise and uncertainty.
Ownership Overview
2.12% Insiders
27.54% Mutual Funds
16.48% Other Institutional Investors
27.93% Public Companies and Individual Investors
PGNY FAQ
What was Progyny, Inc.’s price range in the past 12 months?
Progyny, Inc. lowest stock price was $13.39 and its highest was $30.42 in the past 12 months.
What is Progyny, Inc.’s market cap?
Progyny, Inc.’s market cap is $1.99B.
When is Progyny, Inc.’s upcoming earnings report date?
Progyny, Inc.’s upcoming earnings report date is Aug 07, 2025 which is in 24 days.
How were Progyny, Inc.’s earnings last quarter?
Progyny, Inc. released its earnings results on May 08, 2025. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.19 by -$0.02.
Is Progyny, Inc. overvalued?
According to Wall Street analysts Progyny, Inc.’s price is currently Undervalued.
Does Progyny, Inc. pay dividends?
Progyny, Inc. does not currently pay dividends.
What is Progyny, Inc.’s EPS estimate?
Progyny, Inc.’s EPS estimate is 0.16.
How many shares outstanding does Progyny, Inc. have?
Progyny, Inc. has 85,718,025 shares outstanding.
What happened to Progyny, Inc.’s price movement after its last earnings report?
Progyny, Inc. reported an EPS of $0.17 in its last earnings report, missing expectations of $0.19. Following the earnings report the stock price went down -9.328%.
Which hedge fund is a major shareholder of Progyny, Inc.?
Currently, no hedge funds are holding shares in PGNY
Progyny Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$27.25 (17.41% Upside)
$27.25 (17.41% Upside)
Blogger Sentiment
Neutral
PGNY Sentiment 50%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 218.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $59.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 1.3%
Last 30 Days ▲ 1.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-17.63%
12-Months-Change
Fundamentals
Return on Equity
10.11%
Trailing 12-Months
Asset Growth
-8.06%
Trailing 12-Months
Company Description
Progyny, Inc.
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
PGNY Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Progyny's earnings call reflects strong financial performance and growth potential, highlighted by record revenues, expanded partnerships, and a raised guidance. However, challenges include the transition of a large client and macroeconomic uncertainties impacting pipeline growth. Despite these challenges, the company's strategic expansions and diversified client base provide a positive outlook.Read More>PGNY Stock 12 Month Forecast
Average Price Target
$27.25
▲(17.41%Upside)